MedPath

Triloupe

Brand Name: Triloupe

Generic Name: Polymyxin B Sulfate + Neomycin Sulfate + Dexamethasone (as Sodium Phosphate)

Active
Registration Number

DRP-864-05

Dosage Form

Otic Solution

Issuance Date

April 1, 2022

Expiry Date

January 31, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10,000 units/5 mg/1 mg per mL
PackagingWhite Plastic Dropper-Tipped Bottle x 5 mL Box of 1's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial / Corticosteroid
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

Polymyxin B SulfateActive
Monograph: Polymyxin B
Neomycin SulfateActive
Monograph: Neomycin
Dexamethasone (as Sodium Phosphate)Active
Monograph: dexamethasone (as sodium phosphate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform